Microstructural and functional brain abnormalities in multiple sclerosis predicted by osteopontin and neurofilament light
- PMID: 33813096
- DOI: 10.1016/j.msard.2021.102923
Microstructural and functional brain abnormalities in multiple sclerosis predicted by osteopontin and neurofilament light
Abstract
Background: Osteopontin (OPN) is a proinflammatory biomarker, and neurofilament light chain (NFL) levels reflect axonal damage. Resting-state functional MRI (rs-fMRI) defines brain networks during wakeful rest.
Objective: To examine, if levels of OPN and NFL are associated on the long term with (i) lesion evolution, (ii) changes in normal-appearing white matter (NAWM) microstructure and (iii) functional connectivity in multiple sclerosis (MS).
Methods: Concentration of NFL and OPN in the blood and CSF were related to MRI findings 10.3 ± 2.8 years later in 53 patients with MS. NFL was examined by Simoa method, OPN by ELISA. Lesion volume in the brain and cervical spinal cord was examined by 3D FLAIR images. Voxel-wise images of fractional anisotropy (FA), axial diffusivity (AD), mean diffusivity (MD), and radial diffusivity (RD) were examined by tract-based spatial statistics corrected for gender, age and lesion volume. Metabolites were examined by single-voxel MR-spectroscopy in the NAWM. Fifty-five default mode network connections were examined by rs-fMRI corrected for gender, age, MS subtype and current therapy as covariates.
Results: While NFL in paired serum and CSF positively correlated (p = 0.019), there was no correlation between serum and CSF OPN. Higher OPN levels in the CSF but not in the serum showed association with increased brain WM lesion volume (p = 0.009) in 10.3 ± 2.8 years. Higher OPN in the CSF was associated with reduced FA, increased MD, and reduced RD in different NAWM areas 10.3 ± 2.8 years later. Higher OPN in the serum and CSF were associated with increased connectivity strength between the medial prefrontal cortex (MPFC) and other regions except with inferior parietal lobule. NFL in the CSF and in the serum was associated with decreased connectivity strength except for ventral MPFC-hippocampal formation. Neither serum OPN nor NFL at the time of the MRI were associated with functional connectivity changes.
Conclusion: While serum NFL levels reflects CNS production, OPN in serum and CSF may have different cellular sources. OPN within the CSF but not in the serum may forecast development of lesions and microstructural abnormalities in 10 years, indicating the detrimental role of CNS inflammation on the long-term. Although both OPN and NFL in the CSF were associated with functional connectivity changes in 10 years, NFL was associated with decreased strength possibly indicating general axonal loss. In contrast, the positive association of OPN levels in the CSF with increased connectivity strength in 10 years may point to adaptive re-organization due to inflammatory WM lesions and microstructural changes.
Keywords: Diffusion; Functional connectivity; MR spectroscopy; Multiple sclerosis; NAWM; Neurofilament; Osteopontin; Resting-state; fMRI.
Copyright © 2021. Published by Elsevier B.V.
Conflict of interest statement
Declaration of Competing Interest The Author(s) declare(s) that there is no conflict of interest.
Similar articles
-
Serum neurofilament light chain correlates with myelin and axonal magnetic resonance imaging markers in multiple sclerosis.Mult Scler Relat Disord. 2022 Jan;57:103366. doi: 10.1016/j.msard.2021.103366. Epub 2021 Nov 3. Mult Scler Relat Disord. 2022. PMID: 35158472
-
Plasma neurofilament light levels correlate with white matter damage prior to Alzheimer's disease: results from ADNI.Aging Clin Exp Res. 2022 Oct;34(10):2363-2372. doi: 10.1007/s40520-022-02095-y. Epub 2022 Feb 28. Aging Clin Exp Res. 2022. PMID: 35226303
-
NfL and GFAP in serum are associated with microstructural brain damage in progressive multiple sclerosis.Mult Scler Relat Disord. 2023 Sep;77:104854. doi: 10.1016/j.msard.2023.104854. Epub 2023 Jun 29. Mult Scler Relat Disord. 2023. PMID: 37418931
-
Prognostic significance of neurofilament light in Fingolimod therapy for Multiple Sclerosis: A systemic review and meta-analysis based on randomized control trials.Mult Scler Relat Disord. 2023 Jan;69:104416. doi: 10.1016/j.msard.2022.104416. Epub 2022 Nov 17. Mult Scler Relat Disord. 2023. PMID: 36495843 Review.
-
Neurofilament light chain as a biological marker for multiple sclerosis: a meta-analysis study.Neuropsychiatr Dis Treat. 2018 Sep 3;14:2241-2254. doi: 10.2147/NDT.S173280. eCollection 2018. Neuropsychiatr Dis Treat. 2018. PMID: 30214214 Free PMC article. Review.
Cited by
-
Combination protein biomarkers predict multiple sclerosis diagnosis and outcomes.J Neuroinflammation. 2024 Feb 17;21(1):52. doi: 10.1186/s12974-024-03036-4. J Neuroinflammation. 2024. PMID: 38368354 Free PMC article.
-
New Enhancing MRI Lesions Associate with IL-17, Neutrophil Degranulation and Integrin Microparticles: Multi-Omics Combined with Frequent MRI in Multiple Sclerosis.Biomedicines. 2023 Nov 28;11(12):3170. doi: 10.3390/biomedicines11123170. Biomedicines. 2023. PMID: 38137391 Free PMC article.
-
Circulating microRNAs correlate with structural and functional MRI parameters in patients with multiple sclerosis.Front Mol Neurosci. 2023 Oct 10;16:1173212. doi: 10.3389/fnmol.2023.1173212. eCollection 2023. Front Mol Neurosci. 2023. PMID: 37881368 Free PMC article.
-
Biomarkers in autoimmune diseases of the central nervous system.Front Immunol. 2023 Apr 5;14:1111719. doi: 10.3389/fimmu.2023.1111719. eCollection 2023. Front Immunol. 2023. PMID: 37090723 Free PMC article. Review.
-
Osteopontin Is Associated with Multiple Sclerosis Relapses.Biomedicines. 2023 Jan 11;11(1):178. doi: 10.3390/biomedicines11010178. Biomedicines. 2023. PMID: 36672686 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
